Page 24 - SAMRC AnnualReport 2025-26
P. 24

Professor Liesl Zühlke, SAMRC Vice President of    cooperation between scientists in South Africa
            Extramural Research and Internal Portfolio and Dr   and  Japan  related  to  medical  research  and
            Gugu Moche, NRF Executive Director, serve on the   development. Some of the activities proposed
            HFSPO  Board  of  Trustees.  In  addition,  Professor   under this MoC include joint research projects
            Kelly Chibale from the University of Cape Town     conducted by researchers from both countries, joint
            (UCT) and Unit Director of the SAMRC/UCT Drug      seminars, workshops, and other scientific meetings,
            Discovery and Development Research Unit, serves    as well as personnel exchanges.
            on the HFSPO Council of Scientists.
                                                               AMED was established in 2015 as a funding
            SAMRC and Japan Agency                             agency  tasked  with  promoting  medical  research
            for Medical Research and                           and development and improving the environment
            Development Collaboration                          for research in Japan under their government’s
                                                               Healthcare Policy.
            In  2024,  the  SAMRC  signed  a  Memorandum  of
            Cooperation (MoC) with the Japan Agency for        Following a call for joint projects that was published
            Medical Research and Development (AMED). The       in October 2024, the following three (3) joint projects
            purpose of the MoC is to promote and support       were awarded in April 2025.



              SAMRC-AMED RI PROJECTS
              Genomic Insights into the Pathogenesis of Cancer and Infectious Diseases
              NO.   JOINT PROPOSAL TITLE                               PI'S NAME          PI'S AFFILIATION
              1     Elucidating the cervical cancer malignancy   SA    Deepak Balaji      CSIR
                    mechanisms for precise treatment based on          Thimiri Govindaraj
                    genome comparison and drug sensitivity test
                    of Japanese and South African patient        JP    Yusuke Yamamoto    NCC
                    samples

              2     Deciphering synergistic interactions between   SA  Shaheen Mowla      UCT
                    HIV and EBV in lymphomagenesis through
                    genomic and transcriptomic analyses          JP    Yoshitaka Sato     Nagoya

              3     Discovery and validation of new host-directed   SA  Suraj Parihar     UCT
                    drug targets for tuberculosis in human
                    macrophages                                  JP    Harukazu Suzuki    RIKEN






























            22          SA M R C  A N N U A L R EP O R T 2 0 2 5 / 2 0 2 6
   19   20   21   22   23   24   25   26   27   28   29